Methods and compositions for alteration of a cystic fibrosis transmembrane conductance regulator (CFTR) gene

US9161995B2 · US · B2

Patent metadata
FieldValue
Publication numberUS-9161995-B2
Application numberUS-201213558101-A
CountryUS
Kind codeB2
Filing dateJul 25, 2012
Priority dateJul 25, 2011
Publication dateOct 20, 2015
Grant dateOct 20, 2015

How to read this patent

A practical reading order for non-experts. Skip the full description unless you need deep technical detail.

  1. Title

    What the patent document calls the invention.

  2. Abstract

    A short plain-language summary of the technical disclosure.

  3. Assignees and inventors

    Who owns or filed the patent and who is credited as inventor.

  4. Key dates

    Filing, priority, publication, and grant dates set the timeline.

  5. First independent claim

    The legal scope of protection — read this for what is actually claimed.

  6. CPC / IPC classifications

    Technology tags used to group this patent with similar filings.

  7. Citations and related patents

    Prior art links and similar publications in this corpus.

Abstract

Official abstract text for this publication.

Nucleases and methods of using these nucleases for alteration of a CFTR gene and generation of cells and animal models.

First claim

Opening claim text (preview).

What is claimed is: 1. A protein comprising an engineered zinc finger protein DNA-binding domain, wherein the DNA-binding domain comprises four, five or six zinc finger recognition regions ordered F1 to F4, F1 to F5 or F1 to F6 from N-terminus to C-terminus, and wherein the protein is selected from the group consisting of: (i) a 5-finger zinc finger protein comprising the following recognition regions: F1: WPSCLYA (SEQ ID NO:8); F2: NGVLLKR (SEQ ID NO:9); F3: QSGNLAR (SEQ ID…

Assignees

Inventors

Classifications

Patent family

Related publications grouped by family.

External sources

Next steps

Free tools are coming soon. Tell us what you want to track and we'll notify you.

Frequently asked questions

Answers are generated from the same data shown on this page.

What does patent US9161995B2 cover?
Nucleases and methods of using these nucleases for alteration of a CFTR gene and generation of cells and animal models.
Who is the assignee on this patent?
Guschin Dmitry M, Holmes Michael C, Paschon David, and 2 more
What technology area does this patent fall under?
Primary CPC classification A61K48/005. Mapped technology areas include Human Necessities.
When was this patent published?
Publication date Tue Oct 20 2015 00:00:00 GMT+0000 (Coordinated Universal Time) (B2). Legal status and post-grant events are not shown on this page.
What related patents are in patentsdb?
We list 8 related publications on this page (citations in our corpus or others sharing the same primary CPC).